A Joint Event With:

Intelligently connecting institutions and expertise. Gerson Lehrman Group^® (GLG) is the global marketplace for expertise. Since 1998, GLG has helped the world's leading institutions find insights, broaden professional relationships, and make better investment and business decisions. GLG’s unparalleled network of the world's leading expert consultants, known as the Gerson Lehrman Group Councils, includes more than 250,000 subject-matter experts who connect with decision makers through a wide range of consulting methods, including telephone consultations, in-person meetings, expert surveys, and seminars.  For more information about Gerson Lehrman Group, please visit www.glgroup.com.

Leading Life Sciences companies worldwide use GLG to accelerate business development research and gather superior insights. GLG works with companies in every sector of the Life Sciences industry, from the mid-sized and more specialized organizations to some of the largest pharmaceutical, biotechnology, healthcare services, and medical device and supply companies in the world. The experts in GLG’s network include key opinion and thought leaders, doctors in every therapeutic category, research scientists, executives and former executives, former regulators, reimbursement experts, hospital administrators, and others involved at every point in the life cycle of a drug or device. For more information, please visit www.glgroup.com/LifeSciencesEvents.

Usage Scenarios

Research and Development

A mid-size pharmaceutical firm wants guidance on research and development strategy from a group of scientific leaders and experienced executives for its development personnel and members of the company’s executive management. GLG can help the client design a board of five to seven scientists and former pharmaceutical executives, schedule and coordinate board meetings and leverage the GLG Survey Platform℠ to easily gather written input from board members for analytical purposes.

Commercialization

A biotechnology firm wants advice on the commercial potential of an emerging molecule as it is being developed. GLG can help the client identify three to five key opinion leaders (KOLs) with analogous commercialization expertise to supplement the client’s existing relationships and bring in a GLG Council Partner℠ experienced in board moderation to manage the board, moderate meetings, and produce deliverables based on board member interaction.

Marketing

A global medical device firm is looking to launch an existing product in a new geography with which it has little experience. GLG can help the client pull together a panel of eight to ten practitioners with expertise relevant to both the product and the geography.

The scenarios above are not case studies. Instead, the sampling demonstrates the connectivity and potential of finding and engaging experts from the GLG Councils.

© 2010 Gerson Lehrman Group, Inc. All rights reserved.